Nature Communications (Jul 2021)

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

  • Job van Riet,
  • Harmen J. G. van de Werken,
  • Edwin Cuppen,
  • Ferry A. L. M. Eskens,
  • Margot Tesselaar,
  • Linde M. van Veenendaal,
  • Heinz-Josef Klümpen,
  • Marcus W. Dercksen,
  • Gerlof D. Valk,
  • Martijn P. Lolkema,
  • Stefan Sleijfer,
  • Bianca Mostert

DOI
https://doi.org/10.1038/s41467-021-24812-3
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 14

Abstract

Read online

Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) display heterogeneous clinical and genetic characteristics. Here, the authors investigate the mutational landscape of 85 aNEN by whole genome sequencing and identify distinct subpopulations, tumour mutational burden patterns, drivers and actionable somatic alterations.